⌘K
Loading ticker…
As of 2026-08-24, cbdMD, Inc. Common Stock (YCBD) has a 3-month relative strength percentile of 11 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 39. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 8.0%, relative volume 0.27×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
YCBD is in a stage 4 downtrend, week 6. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -19.9% / -38.5%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
YCBD appears in 1 ETF as of Mar 2026: VXF at 0.00% weight, $38K notional.
Held by 1 ETFs · $38K across latest filings · largest weight 0.00% (VXF).
Top 1 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VXFVanguard Extended Market ETF | 0.00% | $38K | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | YCBD Jan avg: 14.19% median: 14.33% win: 50% σ: 43.76% n: 4 2022-04-12 → 2026-07-31 | YCBD Feb avg: -21.65% median: -22.15% win: 0% σ: 9.80% n: 4 2022-04-12 → 2026-07-31 | YCBD Mar avg: -10.52% median: -19.24% win: 25% σ: 34.48% n: 4 2022-04-12 → 2026-07-31 | YCBD Apr avg: -10.54% median: -5.44% win: 40% σ: 33.25% n: 5 2022-04-12 → 2026-07-31 | YCBD May avg: -25.16% median: -39.64% win: 20% σ: 23.30% n: 5 2022-04-12 → 2026-07-31 | YCBD Jun avg: -19.72% median: -15.02% win: 0% σ: 11.26% n: 5 2022-04-12 → 2026-07-31 | YCBD Jul avg: -2.63% median: 0.58% win: 60% σ: 12.97% n: 5 2022-04-12 → 2026-07-31 | YCBD Aug avg: -15.34% median: -17.24% win: 0% σ: 6.32% n: 4 2022-04-12 → 2026-07-31 (current) | YCBD Sep avg: -0.87% median: -11.80% win: 25% σ: 45.63% n: 4 2022-04-12 → 2026-07-31 | YCBD Oct avg: -3.90% median: -9.61% win: 50% σ: 40.00% n: 4 2022-04-12 → 2026-07-31 | YCBD Nov avg: -8.08% median: -10.81% win: 25% σ: 20.72% n: 4 2022-04-12 → 2026-07-31 | YCBD Dec avg: 31.81% median: 16.33% win: 50% σ: 66.25% n: 4 2022-04-12 → 2026-07-31 |